InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Auchincloss Thomas G, Director. Officer active across 1 company, notably Concert Pharmaceuticals, INC.. Aggregated, 5 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €27k. History available since 6 June 2022. The latest transaction was disclosed on 6 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
17,625 sharesCommon StockSEC:0001209191-23-016160:0
16,400 sharesCommon StockSEC:0001209191-22-036284:0
6,000 shares@ US$4.75100.0% of flowCommon StockSEC:0001209191-22-034579:0
Ideal exit: 3 Mar 2023 (T+270)
5,125 sharesCommon StockSEC:0001209191-21-039741
5,125 sharesCommon StockSEC:0001209191-21-039741:0
5 of 5 declarations
About Auchincloss Thomas G
Thomas G. Auchincloss is a Board Member at Concert Pharmaceuticals, Inc. He contributes to the strategic direction of the company, bringing his expertise in biotechnology and product development. His role is essential in supporting innovation and growth.
